Xiaofeng Zhou
Xiaofeng Zhou, (周晓峰) associate professor, Center for Molecular Biology of Oral Diseases, University of Illinois at Chicago College of Dentistry, is an internationally known oral cancer researcher.His primary research interest is to utilize molecular genetics and bioinformatics technologies to develop novel diagnostic tools and to gain a better understanding of human diseases such as head and neck/oral cancer. His research is focused on the genetic mapping of disease genes and/or consistent genomic alterations that are associated with the development and progression of oral cancer.
Zhou previously had been an assistant professor of oral biology at the University of California, Los Angeles (UCLA) School of Dentistry, and also was a member of UCLA’s Jonsson Comprehensive Cancer Center and the university’s Dental Research Institute. He holds a BS in biochemistry and microbiology from Hangzhou University in China; a PhD in biochemistry and a postdoctorate training in human genetics from Boston University; and an MS in software engineering from Brandeis University.
Zhou has published more than 80 journal articles, review articles, and book chapters, and holds three National Institutes of Health grant research projects.
Zhou is also a visiting professor at Sun Yat-sen University, China. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Xiaofeng Zhou', query time: 0.02s
Refine Results
-
1
The analgesic effects of erector-spinae plane block on hip arthroplasty: A meta-analysis by Xiaofeng Zhou, Yifan Qin, Chetan Bohara, Jin Wu
Published 2025-02-01
Article -
2
Two-Dimensional Materials Based Optoelectronics by Yu Chen, Jun Liu, Jizhou Jiang, Xiaofeng Zhou, Shuqing Chen, Yan Luo
Published 2017-01-01
Article -
3
CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions by Lei Huang, Yalei Wen, Qin Guo, Caishi Zhang, Xiao Yang, Mei Li, YiXia Liu, Xinying Li, Jiaxin Tang, Xiaofeng Zhou, Qi Qi, Haoxing Zhang, Tongzheng Liu
Published 2025-01-01
Article -
4
Prevalence and characterization of IncQ1α-mediated multi-drug resistance in Proteus mirabilis Isolated from pigs in Kunming, Yunnan, China by Hongmei Liu, Hongmei Liu, Hongmei Liu, Na Xia, Fanan Suksawat, Bundit Tengjaroenkul, Yue Hu, Xiaofeng Zhou, Xiaojiang Li, Cuiqin Huang, Yinli Bao, Qiong Wu, Chunrong Zhang, Sunpetch Angkititrakul, Bin Xiang, Xin Wu
Published 2025-01-01
Article -
5
Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment by Qiuming Zou, Xiaofeng Zhou, Jianqin Lai, Haixia Zhou, Jinxuan Su, Zhijing Zhang, Xiaosong Zhuang, Lili Liu, Ruijie Yuan, Sijia Li, Siyu Yang, Xinyi Qu, Jiezhu Feng, Yongqi Liu, Zisheng Li, Shiting Huang, Zhi Shi, Yu Yan, Zhiming Zheng, Wencai Ye, Qi Qi
Published 2025-02-01
Article -
6
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial by Guoshuang Shen, Zhilin Liu, Miaozhou Wang, Yi Zhao, Xinlan Liu, Yujin Hou, Wenbiao Ma, Jingqi Han, Xiaofeng Zhou, Dengfeng Ren, Fuxing Zhao, Zitao Li, Shifen Huang, Yongzhi Chen, Yingjian He, Yan Liu, Zijun Zhu, Yongxin Li, Jinming Li, Mengting Da, Hongnan Mo, Feng Du, Liang Cui, Jing Bai, Zhen Liu, Fei Ma, Jiuda Zhao
Published 2025-02-01
Article